BioSpace News Archive

Press Releases

Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook

March 6, 2025
·
11 min read
Press Releases

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

March 6, 2025
·
6 min read
Press Releases

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 6, 2025
·
14 min read
Press Releases

scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease

March 6, 2025
·
7 min read
Press Releases

Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies

March 6, 2025
·
4 min read
Press Releases

Lexicon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

March 6, 2025
·
15 min read
Press Releases

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2024 Earnings Call and Participation in Upcoming Investor Conference

March 6, 2025
·
2 min read
Press Releases

Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones

March 6, 2025
·
11 min read
Press Releases

Medtronic announces cash dividend for fourth quarter of fiscal year 2025

March 6, 2025
·
1 min read
Press Releases

Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

March 6, 2025
·
10 min read